Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

A17, You bring up good points. “NP just does

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Saltz Member Profile
 
Followed By 18
Posts 1,268
Boards Moderated 0
Alias Born 03/05/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2020 4:29:33 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/9/2020 4:08:38 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/27/2019 5:22:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/27/2019 4:28:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2019 8:34:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/17/2019 4:33:44 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/13/2019 5:29:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2019 5:15:42 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2019 9:27:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2019 9:06:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 8:01:40 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 12/4/2019 8:24:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2019 12:14:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/20/2019 12:12:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/20/2019 9:26:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 9:06:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 11:35:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 8:31:48 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 11/12/2019 7:07:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/7/2019 9:13:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 8:36:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 5:07:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2019 8:16:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:10:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:06:29 PM
Saltz   Monday, 10/21/19 10:29:32 AM
Re: Amatuer17 post# 47473
Post # of 54022 
A17,

You bring up good points.

“NP just does not have skills, experience or capability to take the product to market.
In fact I am doubtful if his BLA submission will be clean enough to get approval in first round even after rolling BLA. “

I know that Nader will have the final BLA Package reviewed by an outside source to insure all of the boxes have been checked. If he were to submit an unacceptable package that would cost us another six months which we do not have. That too cost $. Plane and simple lack of $ is delaying the completion of the BLA.

Nader made a critical miscalculation by perusing the Cancer indications rather than devoting all resources to completing the BLA. He has left himself in a corner in terms of financing.

I agrees that Nader lacks the skills and has no credibility. He has proven this. I will eat my words joyously if he pulls off the deal he is currently touting. My gut feeling is why would this turn out any differently than anything of his previous promises? He has been consistently unable to deliver sense the infamous Golden Quarter he so gregariously promised.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist